Clinical effect of triamcinolone acetonide (pstA) combined with modified grid photocoagulation in the treatment of macular edema secondary to retinal vein occlusion (rvo-me)
Objective To analyze the clinical effect of improved grid photocoagulation combined with triamcinolone (PSTA) in the treatment of patients with macular edema secondary to retinal vein occlusion (RVO-ME). Methods In this study, 68 RVO-ME patients admitted to the outpatient department of our hospital from January 2021 to January 2022 were divided by randomized double-blind method, 34 patients in the control group received improved laser grating photocoagulation therapy, and 34 patients in the study group received PSTA combined with improved grating photocoagulation therapy. Complications, visual acuity level, edema improvement, macular fovea thickness and intraocular pressure were compared between the two groups. Results After treatment, the visual acuity level of the study group was higher than that of the control group, the difference was statistically significant (P＜0.05). The intraocular pressure level and macular fovea thickness of the two groups after treatment were lower in the study group than in the control group, the difference was statistically significant (P＜0.050). The reduction rate of edema in the study group (85.29％) was higher than that in the control group (64.71％), and the difference was statistically significant (P＜0.05). After 3 months of follow-up, CLVQOL score of the study group was higher than that of the control group, and the difference was statistically significant (P＜0.05). Conclusion For RVO-ME patients, improved grid photocoagulation combined with PSTA can effectively improve the visual acuity level of patients, reduce the symptoms of edema and improve the quality of life of patients.
improved grid photocoagulationTriamcinolonemacular edema secondary to retinal vein occlusionlevel of vision
马楠、He Jing、王淑珍
展开 >
河北省张家口市第一医院眼科,河北 张家口 075000
Ophthalmology Department, The First Hospital of Zhangjiakou, Zhangjiakou 075000, China
万方数据
